The COVID-19 pandemic has generated an unprecedented amount of novel and repurposed vaccines and therapeutics that have been rapidly developed and implemented into clinical use. Unfortunately, pregnant persons have been excluded from most phase III clinical studies; therefore, our understanding regarding their safety for use in this population stems from understanding of theoretic risks and observational data. In this review, the authors discuss pregnancy-specific considerations for COVID-19 therapeutics.
All Keywords
【저자키워드】 COVID-19, Vaccines, Therapeutics, Pregnancy,
【저자키워드】 COVID-19, Vaccines, Therapeutics, Pregnancy,